Clinical Trial Update: Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 2 study evaluating hydrocortisone ophthalmic ointment 0.5% for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Hydrocortisone ophthalmic ointment 0.5% (hydrocortisone)

Snippet

Sponsor: Koffler Vision Group | Conditions: Allergic Conjunctivitis | Phase 2 | Status: TERMINATED